A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Trial details
- Registry ID
- NCT06568627
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as EX-03
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)NCT06568627 | MDWD | Phase 3 | Recruiting | 2026-12Estimated |
| Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)NCT06690177 | MDWD | Phase 2 | Not yet recruiting | 2028-11-04Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |